HomeCompareNH vs EQR

NH vs EQR: Dividend Comparison 2026

NH yields 148.15% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NH wins by $23.42M in total portfolio value
10 years
NH
NH
● Live price
148.15%
Share price
$1.35
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.46M
Annual income
$10,076,148.54
Full NH calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — NH vs EQR

📍 NH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNHEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NH + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NH pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NH
Annual income on $10K today (after 15% tax)
$12,592.59/yr
After 10yr DRIP, annual income (after tax)
$8,564,726.26/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, NH beats the other by $8,561,479.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NH + EQR for your $10,000?

NH: 50%EQR: 50%
100% EQR50/50100% NH
Portfolio after 10yr
$11.75M
Annual income
$5,039,984.07/yr
Blended yield
42.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

NH
Analyst Ratings
6
Buy
Consensus: Buy
Altman Z
-13.1
Piotroski
3/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NH buys
0
EQR buys
0
No recent congressional trades found for NH or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNHEQR
Forward yield148.15%4.73%
Annual dividend / share$2.00$2.77
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$23.46M$40.5K
Annual income after 10y$10,076,148.54$3,819.61
Total dividends collected$21.69M$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold

Year-by-year: NH vs EQR ($10,000, DRIP)

YearNH PortfolioNH Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$25,515$14,814.81$11,248$547.57+$14.3KNH
2$62,628$35,326.85$12,701$666.53+$49.9KNH
3$148,051$81,039.20$14,405$814.59+$133.6KNH
4$337,457$179,042.34$16,413$999.84+$321.0KNH
5$742,477$381,398.70$18,795$1,232.92+$723.7KNH
6$1,578,712$784,260.93$21,639$1,527.95+$1.56MNH
7$3,247,684$1,558,462.68$25,057$1,903.80+$3.22MNH
8$6,471,310$2,996,288.20$29,197$2,385.87+$6.44MNH
9$12,504,097$5,579,794.89$34,250$3,008.70+$12.47MNH
10$23,455,532$10,076,148.54$40,467$3,819.61+$23.42MNH

NH vs EQR: Complete Analysis 2026

NHStock

NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers Quadris, a data solution that includes multi-data analysis, reporting, and professional services. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.

Full NH Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this NH vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NH vs SCHDNH vs JEPINH vs ONH vs KONH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.